Internally displaced people, referred to as IDPs, have been forced to flee their homes by conflict, violence, persecution or disasters, however, they remain within the borders of their own country. At ...

For many Filipinos, receiving a medical diagnosis is supposed to provide clarity. But for those with rare diseases, it often ...

The company saw significant growth in market capitalization during 2020 and 2021, which helped Musk join the ranks of the world’s top 10 richest people by September 2021. At its peak in November ...

central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia." According to the Company, "[t]he CRL indicates that the FDA completed its ...

The Company’s lead drug candidate, govorestat, is a central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases, including Galactosemia.